Local Institution - 0128

Toronto, Ontario M5G 2M9

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma — Running, not enrolling